药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orciprenaline
Trilostane
The therapeutic efficacy of Trilostane can be decreased when used in combination with Tubocurarine.
Orciprenaline
Fosphenytoin
The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Tubocurarine.
Orciprenaline
Azosemide
Azosemide may decrease the neuromuscular blocking activities of Tubocurarine.
Orciprenaline
Piretanide
Piretanide may decrease the neuromuscular blocking activities of Tubocurarine.
Orciprenaline
Lithium cation
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lithium cation.
Orciprenaline
Lemborexant
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lemborexant.
Orciprenaline
JNJ-26489112
The risk or severity of adverse effects can be increased when Tubocurarine is combined with JNJ-26489112.
Orciprenaline
Solriamfetol
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Solriamfetol.
Orciprenaline
Bentazepam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Bentazepam.
Orciprenaline
Pyrazolam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pyrazolam.
Orciprenaline
Cinazepam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Cinazepam.
Orciprenaline
Oxazepam acetate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Oxazepam acetate.
Orciprenaline
Perphenazine enanthate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Perphenazine enanthate.
Orciprenaline
Eslicarbazepine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Eslicarbazepine.
Orciprenaline
Lithium carbonate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lithium carbonate.
Orciprenaline
Aripiprazole lauroxil
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Aripiprazole lauroxil.
Orciprenaline
Cannabidivarin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Cannabidivarin.
Orciprenaline
Nordazepam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Nordazepam.
Orciprenaline
5-methoxy-N,N-dimethyltryptamine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with 5-methoxy-N,N-dimethyltryptamine.
Orciprenaline
MRK-409
The risk or severity of adverse effects can be increased when Tubocurarine is combined with MRK-409.